Status:
NOT_YET_RECRUITING
The Effectiveness of NeuroBot in Alleviating Anxiety of Patients Undergoing Neurovascular Surgeries
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
The Hong Kong Polytechnic University
Hospital Authority, Hong Kong
Conditions:
Anxiety
Patient Compliance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this randomized controlled trial is to investigate the effectiveness of NeuroBot in alleviating anxiety of patients undergoing neurovascular procedures. The main questions it aims to answe...
Detailed Description
The NeuroBot is co-developed by the neurosurgeons, nuerosurgical specialty nurses in Queen Elisabeth Hospital and AI experts from the Hong Kong Polytechnic University and the Chinese University of Hon...
Eligibility Criteria
Inclusion
- aged above 18 years;
- scheduled for elective neuroendovascular surgery;
- able to understand Chinese and read Chinese;
- mobile device with internet capability.
Exclusion
- identified cognitive impairment or have difficulty in understanding study procedures, following instructions, or providing informed consent;
- prior exposure to health chatbot to acquire health-related information in previous 3 months;
- have neurovascular surgeries before
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2027
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT07144540
Start Date
October 1 2025
End Date
May 30 2027
Last Update
August 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong
2
The Chinese University of Hong Kong
Hong Kong, Hong Kong